ScoreWhy is Walvax Biotechnology Co., Ltd. ?
1
Poor long term growth as Net Sales has grown by an annual rate of -5.90% and Operating profit at -32.17% over the last 5 years
2
With a growth in Net Profit of 4082.41%, the company declared Very Positive results in Mar 26
- The company has declared positive results for the last 2 consecutive quarters
- ROCE(HY) Highest at 3.39%
- INVENTORY TURNOVER RATIO(HY) Highest at 1.14 times
- PRE-TAX PROFIT(Q) Highest at CNY 148.23 MM
3
With ROE of 3.40%, it has a attractive valuation with a 2.36 Price to Book Value
- Over the past year, while the stock has generated a return of 13.61%, its profits have risen by 117.3% ; the PEG ratio of the company is 0.6
- At the current price, the company has a high dividend yield of 0.3
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to Walvax Biotechnology Co., Ltd. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Walvax Biotechnology Co., Ltd. for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
Walvax Biotechnology Co., Ltd.
12.77%
0.04
43.78%
China Shanghai Composite
21.43%
1.55
13.83%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
-5.90%
EBIT Growth (5y)
-32.17%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.32
Sales to Capital Employed (avg)
0.30
Tax Ratio
Tax Ratio is Negative%
Dividend Payout Ratio
139.51%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
13.84%
ROE (avg)
9.19%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
69
Industry P/E
Price to Book Value
2.36
EV to EBIT
106.67
EV to EBITDA
37.79
EV to Capital Employed
2.29
EV to Sales
7.47
PEG Ratio
0.59
Dividend Yield
0.28%
ROCE (Latest)
2.14%
ROE (Latest)
3.40%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Sideways
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Mildly Bullish
Dow Theory
Mildly Bullish
Mildly Bearish
OBV
Mildly Bullish
Mildly Bearish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend27What is working for the Company
ROCE(HY)
Highest at 3.39%
INVENTORY TURNOVER RATIO(HY)
Highest at 1.14 times
PRE-TAX PROFIT(Q)
Highest at CNY 148.23 MM
NET PROFIT(Q)
Highest at CNY 127.59 MM
RAW MATERIAL COST(Y)
Fallen by -6.44% (YoY
OPERATING PROFIT MARGIN(Q)
Highest at 29.26 %
-18What is not working for the Company
OPERATING CASH FLOW(Y)
Lowest at CNY 635.8 MM
INTEREST COVERAGE RATIO(Q)
Lowest at 1,840.69
CASH AND EQV(HY)
Lowest at CNY 2,322.81 MM
DEBT-EQUITY RATIO
(HY)
Highest at 5.89 %
NET SALES(Q)
Lowest at CNY 443.85 MM
INTEREST(Q)
Highest at CNY 7.06 MM
Here's what is working for Walvax Biotechnology Co., Ltd.
Pre-Tax Profit
At CNY 148.23 MM has Grown at 615.22%
Year on Year (YoY)MOJO Watch
Near term Pre-Tax Profit trend is very positive
Pre-Tax Profit (CNY MM)
Net Profit
At CNY 127.59 MM has Grown at 1,210.36%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is very positive
Net Profit (CNY MM)
Pre-Tax Profit
Highest at CNY 148.23 MM and Grown
In each period in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is very positive
Pre-Tax Profit (CNY MM)
Net Profit
Highest at CNY 127.59 MM and Grown
In each period in the last five periodsMOJO Watch
Near term Net Profit trend is very positive
Net Profit (CNY MM)
Inventory Turnover Ratio
Highest at 1.14 times and Grown
In each half year in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its inventory faster
Inventory Turnover Ratio
Operating Profit Margin
Highest at 29.26 %
in the last five periodsMOJO Watch
Company's profit margin has improved
Operating Profit to Sales
Raw Material Cost
Fallen by -6.44% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Walvax Biotechnology Co., Ltd.
Interest
At CNY 7.06 MM has Grown at inf%
period on period (QoQ)MOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (CNY MM)
Interest Coverage Ratio
Lowest at 1,840.69
in the last five periodsMOJO Watch
The company's ability to manage interest payments is deteriorating
Operating Profit to Interest
Operating Cash Flow
Lowest at CNY 635.8 MM
in the last three yearsMOJO Watch
The company's cash revenues from business operations are falling
Operating Cash Flows (CNY MM)
Net Sales
Lowest at CNY 443.85 MM
in the last five periodsMOJO Watch
Near term sales trend is negative
Net Sales (CNY MM)
Interest
Highest at CNY 7.06 MM
in the last five periods and Increased by inf% (QoQ)MOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (CNY MM)
Cash and Eqv
Lowest at CNY 2,322.81 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is deteriorating
Cash and Cash Equivalents
Debt-Equity Ratio
Highest at 5.89 %
in the last five Semi-Annual periodsMOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed
Debt-Equity Ratio
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
